甲苯达唑增强三阴性乳腺癌的放射治疗作用
本研究通过高通量筛选发现甲苯达唑(MBZ)可阻止辐射诱导三阴性乳腺癌(TNBC)细胞转化为乳腺癌起始细胞(BCIC),并评估其体外和体内增强放射治疗(RT)效果的作用。MBZ有效清除BCIC池、阻止辐射诱导的BCIC转化,使细胞阻滞于G2/M期并引起双链断裂和凋亡,在体外和体内使TNBC细胞对电离辐射敏感,在人TNBC异种移植模型中改善肿瘤控制。作者认为数据支持将MBZ作为与RT联合的治疗方案重新用于TNBC患者。
要点
- 高通量筛选发现甲苯达唑(MBZ)可阻止辐射诱导TNBC细胞获得癌症起始表型并对TNBC细胞有显著毒性。
- MBZ有效清除乳腺癌起始细胞(BCIC)池并阻止电离辐射诱导的BCIC转化。
- MBZ使TNBC细胞对电离辐射敏感,在人TNBC异种移植模型中改善肿瘤控制。
核心结论
- 本研究数据支持将甲苯达唑(MBZ)作为与放射治疗联合的治疗方案重新用于三阴性乳腺癌(TNBC)患者。
研究设计与样本
- 采用高通量筛选鉴定能阻止TNBC细胞辐射诱导转化为癌症起始表型且对TNBC细胞有显著毒性的药物,MBZ为符合标准的药物之一。
- 使用BCIC标志物和乳腺球形成实验研究MBZ对BCIC群体的影响。
- 采用碘化丙啶、膜联蛋白-V和γ-H2AX染色检测MBZ对细胞周期、凋亡和双链断裂的影响。
- 在体外和体内评估MBZ增强TNBC放射治疗效果的潜力,并在人TNBC异种移植模型中评价肿瘤控制。
主要发现
- MBZ有效清除BCIC池并阻止电离辐射诱导乳腺癌细胞转化为治疗抵抗的BCIC。
- MBZ使细胞阻滞于细胞周期的G2/M期并引起双链断裂和凋亡。
- MBZ在体外和体内使TNBC细胞对电离辐射敏感,在人TNBC异种移植模型中改善肿瘤控制。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The lack of a molecular target in triple-negative breast cancer (TNBC) makes it one of the most challenging breast cancers to treat. Radiation therapy (RT) is an important treatment modality for managing breast cancer; however, we previously showed that RT can also reprogram a fraction of the surviving breast cancer cells into breast cancer-initiating cells (BCICs), which are thought to contribute to disease recurrence. In this study, we characterize mebendazole (MBZ) as a drug with potential to prevent the occurrence of radiation-induced reprogramming and improve the effect of RT in patients with TNBC. METHODS AND MATERIALS: A high-throughput screen was used to identify drugs that prevented radiation-induced conversion of TNBC cells into cells with a cancer-initiating phenotype and exhibited significant toxicity toward TNBC cells. MBZ was one of the drug hits that fulfilled these criteria. In additional studies, we used BCIC markers and mammosphere-forming assays to investigate the effect of MBZ on the BCIC population. Staining with propidium iodide, annexin-V, and γ-H2AX was used to determine the effect of MBZ on cell cycle, apoptosis, and double-strand breaks. Finally, the potential for MBZ to enhance the effect of RT in TNBC was evaluated in vitro and in vivo. RESULTS: MBZ efficiently depletes the BCIC pool and prevents the ionizing radiation-induced conversion of breast cancer cells into therapy-resistant BCICs. In addition, MBZ arrests cells in the G2/M phase of the cell cycle and causes double-strand breaks and apoptosis. MBZ sensitizes TNBC cells to ionizing radiation in vitro and in vivo, resulting in improved tumor control in a human xenograft model of TNBC. CONCLUSIONS: The data presented in this study support the repurposing of MBZ as a combination treatment with RT in patients with TNBC.
引用
- Zhang L, Bochkur Dratver M, Yazal T, et al. Mebendazole Potentiates Radiation Therapy in Triple-Negative Breast Cancer. Int J Radiat Oncol Biol Phys. 2018. PMID: 30196056. doi:10.1016/j.ijrobp.2018.08.046
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。